Article Details
Retrieved on: 2022-06-09 16:25:59
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Alnylam Pharmaceuticals said its genetic medicine for a type of kidney condition succeeded in a Phase 2 trial, reporting Thursday that the ...
Article found on: www.biopharmadive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here